Periodic Reporting for period 1 - II-LCA (Integrated Imaging in live Cell Analysis (II-LCA), for enhanced development and manufacturing of biologic and cell therapies.)

The global demand for medicines is rapidly increasing as people live longer, diagnostic methods improve, and the treatment of rare diseases evolve. Biologic drugs and cell therapies represent the next wave of therapeutics being developed to target diseases in a highly specific...